Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,990 public trials 1,516 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Recruiting

Abatacept in Immune Checkpoint Inhibitor Myocarditis

NCT05335928

Conditions
Cancer, Cardiomyopathies, Cardiovascular Diseases, +4 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • MedStar Health Research Institute, Georgetown University Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 31 locations
View Trial Details
Recruiting

A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07660432

Conditions
Neoplasms, Neoplasms, Malignant
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
View Trial Details
Recruiting

TheraSphere Japan Pre-Market Study

NCT07377487

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Hyogo College of Medicine Hospital Nishinomiya, Hyōgo, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo Ku, Tokyo, Japan
View Trial Details
Recruiting

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

NCT06678659

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • SCRI Oncology Partners - PPDS Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details
Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

NCT07630974

Conditions
Malignant Neoplasm, Neoplasms
Locations
  • University of Iowa Hospitals ( Site 4017) Iowa City, Iowa, United States
  • Dana Farber Cancer Center ( Site 4013) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 4008) New Brunswick, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center ( Site 4010) New York, United States
View all 20 locations
View Trial Details

Related conditions